Literature DB >> 10422958

Sildenafil ameliorates effects of inhaled nitric oxide withdrawal.

A M Atz1, D L Wessel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10422958     DOI： 10.1097/00000542-199907000-00041

Source DB:  PubMed          Journal:  Anesthesiology        ISSN： 0003-3022            Impact factor:   7.892


× No keyword cloud information.
  58 in total

Review 1.  Clinical update on sildenafil citrate.

Authors:  Ian H Osterloh; Alan Riley
Journal:  Br J Clin Pharmacol       Date:  2002-03       Impact factor: 4.335

2.  Sildenafil for "blue babies". Such unlicensed drug use might be justified as last resort.

Authors:  James Oliver; David J Webb
Journal:  BMJ       Date:  2002-11-16

Review 3.  Review of inhaled nitric oxide in the pediatric cardiac surgery setting.

Authors:  Paul A Checchia; Ronald A Bronicki; Brahm Goldstein
Journal:  Pediatr Cardiol       Date:  2012-04       Impact factor: 1.655

4.  Endothelial dysfunction enhances vasoconstriction due to scavenging of nitric oxide by a hemoglobin-based oxygen carrier.

Authors:  Binglan Yu; Mohd Shahid; Elena M Egorina; Mikhail A Sovershaev; Michael J Raher; Chong Lei; Mei X Wu; Kenneth D Bloch; Warren M Zapol
Journal:  Anesthesiology       Date:  2010-03       Impact factor: 7.892

5.  Sildenafil--a possible treatment for acute pulmonary hypertension during cardiac surgery.

Authors:  Wendy Wheeler; Shelly Hayes; Ngo Nguyen; Anthony M Cilla; Joseph Rybowicz; Comeco C Jones; Michael A E Ramsay; Shelley A Hall; Dan Meyer; John Capehart; Michael E Jessen; Steves Ring
Journal:  Proc (Bayl Univ Med Cent)       Date:  2002-01

Review 6.  Severe paediatric pulmonary hypertension: new management strategies.

Authors:  A Rashid; D Ivy
Journal:  Arch Dis Child       Date:  2005-01       Impact factor: 3.791

Review 7.  Therapeutic applications of sildenafil citrate in the management of paediatric pulmonary hypertension.

Authors:  Leah Leibovitch; Ilan Matok; Gideon Paret
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 8.  Nitric oxide and beyond: new insights and therapies for pulmonary hypertension.

Authors:  R H Steinhorn
Journal:  J Perinatol       Date:  2008-12       Impact factor: 2.521

Review 9.  Pharmacotherapy for pulmonary hypertension.

Authors:  Robin H Steinhorn
Journal:  Pediatr Clin North Am       Date:  2012-08-26       Impact factor: 3.278

10.  Postoperative use of oral sildenafil in pediatric patients with congenital heart disease.

Authors:  Ju Yeon Uhm; Won-Kyoung Jhang; Jeong-Jun Park; Dong-Man Seo; Sung-Cheol Yun; Tae-Jin Yun
Journal:  Pediatr Cardiol       Date:  2010-01-07       Impact factor: 1.655
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.